Prof Dirk Arnold

Dirk Arnold is currently Associate Professor of Medicine at the Department of Haematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany. In this institution, he leads the Gastrointestinal Cancer Unit and Phase I Trials Unit. Before relocating to Halle, he completed his medical degree at the Universities of Ulm and Berlin, Germany, and undertook specialist training mostly at Charité, Humboldt University, Berlin.

Dr Arnold’s main research interests include the treatment of gastrointestinal cancers, particularly colorectal and gastric carcinomas, focusing on molecular-targeted therapies, and EGFR and other post-translational signal transduction pathways. Another focus of interest is multimodal treatment of rectal cancer, as well as renal cell and head and neck cancers.

Dr Arnold is the Secretary of the Colorectal Cancer Study Group of the German Association of Medical Oncology (AIO) group and member of the “Task Force Colorectal Cancer” of the EORTC and is therefore involved in many ongoing phase I–III trials in gastrointestinal cancer. He is key member of several German and other international cancer societies, including the American Society of Clinical Oncology (ASCO) and the European Society of Medical Oncology (ESMO). In his function in the German Cancer Society, he is a member of the central board of evaluation of Colon Cancer Centres and was involved in the process of the German treatment guideline for colorectal cancer. Dr Arnold has co-authored more than 50 articles in peer-reviewed journals and more than 120 abstracts at international/national meetings.